FDA Grants Accelerated Approval to AstraZeneca Kidney Disease Treatment
The FDA approved AstraZeneca’s treatment for adults with immunoglobulin A nephropathy, a rare kidney disease that can lead to renal failure.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.